# The Efficacy and Safety of Ta1 for Sepsis

> **NCT02867267** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 1106 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Thymosin alpha 1
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02867267
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-06
- **Primary completion:** 2021-01-22
- **Final completion:** 2021-03-23
- **Target enrollment:** 1106 (ACTUAL)
- **Last updated:** 2023-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867267, "The Efficacy and Safety of Ta1 for Sepsis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02867267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*